371
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Effects of Maternal Exposure to Cadmium Oxide Nanoparticles During Pregnancy on Maternal and Offspring Kidney Injury Markers Using a Murine Model

, , , &
Pages 711-724 | Received 19 Dec 2014, Accepted 03 Mar 2015, Published online: 19 Jun 2015

REFERENCES

  • Agency for Toxic Substances and Disease Registry. 2008. Toxicological profile for cadmium. Draft for public comment. Atlanta, GA: U.S. Department of Health and Human Services.
  • Akesson, A., Lundh, T., Vahter, M., Bjellerup, P., Lidfeldt, J., Nerbrand, C., Samsioe, G., Strömberg, U., and Skerfving, S. 2005. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 113: 1627–1631.
  • Barker, D. J., and Martyn, C. N. 1992. The maternal and fetal origins of cardiovascular disease. J. Epidemiol. Commun. Health 46: 8–11.
  • Bentolila, L. A., Michalet, X., Pinaud, F. F., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., and Weiss, S. 2005. Quantum dots for molecular imaging and cancer medicine. Discov. Med. 5: 213–218.
  • Blum, J. L., Nyagode, B. A., James, M. O., and Denslow, N. D. 2008. Effects of the pesticide methoxychlor on gene expression in the liver and testes of the male largemouth bass (Micropterus salmoides). Aquat. Toxicol. 86: 459–469.
  • Blum, J. L., Xiong, J. Q., Hoffman, C., and Zelikoff, J. T. 2012. Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth. Toxicol. Sci. 126: 478–488.
  • Blum, J. L., Rosenblum, L. K., Grunig, G., Beasley, M. B., Xiong, J. Q., and Zelikoff, J. T. 2014. Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model. Inhal. Toxicol. 26: 48–58.
  • Bull, S. 2010. Cadmium toxicological overview. Health Protection Agency. Version 3. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337542/hpa_cadmium_toxicological_overview_v3.pdf
  • Braun, A., Ernst, H., Homann, H. G., and Rittinghausen, S. 2004. Respiratory tract. In The laboratory mouse, ed. H. Hedrich, 2nd ed., 225–243. New York, NY: Elsevier Academic Press.
  • Chan, H. M., Zhu, L. F., Zhong, R., Grant, D., Goyer, R. A., and Cherian, M. G. 1993. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol. Appl. Pharmacol. 123: 89–96.
  • Comité Scientifique de Toxicologie, Ecotoxicologie et l’Environnement. 2004. Opinion on the results of the risk assessment of: cadmium metal human health and cadmium oxide human health carried out in the framework of Council Regulation (EEC) 793/93 on the evaluation and control of the risks of existing substances. CSTEE. http://ec.europa.eu/health/archive/ph_risk/committees/sct/documents/out228_en.pdf
  • Cupertino, M. C., Costa, K. L., Santos, D. C., Novaes, R. D., Condessa, S. S., Neves, A. C., Oliveira, J. A., and Matta, S. L. 2013. Long-lasting morphofunctional remodelling of liver parenchyma and stroma after a single exposure to low and moderate doses of cadmium in rats. Int. J. Exp. Pathol. 94: 343–345.
  • Dorian, C., and Klaassen, C. D. 1995. Protection by zinc-metallothionein (ZnMT) against cadmium-metallothionein-induced nephrotoxicity. Fundam. Appl. Toxicol. 26:99–106.
  • Fels, L. M. 1999. Risk assessment of nephrotoxicity of cadmium. Renal Fail. 21: 275–281.
  • Ferguson, K. K., O’Neill, M. S., and Meeker, J. D. 2013. Environmental contaminant exposures and preterm birth: A comprehensive review. J. Toxicol. Environ. Health B Crit. Rev. 16: 69–113.
  • Ginsberg, G. L. 2012. Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 75: 374–390.
  • Grawé, K. P., and Oskarsson, A. 2000. Cadmium in milk and mammary gland in rats and mice. Arch. Toxicol. 73: 519–527.
  • Haddam, N., Samira, S., Dumont, X., Taleb, A., Lison, D., Haufroid, V., and Bernard, A. 2011. Confounders in the assessment of the renal effects associated with low-level urinary cadmium: An analysis in industrial workers. Environ. Health 10: 37–46.
  • Hales, C. N., and Barker, D. J. 1992. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35: 595–601.
  • Halim, M. A. 2013. Harnessing sun’s energy with quantum dots based solar cells. Nanomaterials 3: 22–47.
  • Jacquillet, G., Barbier, O., Rubera, I., Tauc, M., Borderie, A., Namorado, M. C., Martin, D., Sierra, G., Reyes, J. L., Poujeol, P., and Cougnon, M. 2007. Cadmium causes delayed effects on renal function in the offspring of cadmium-contaminated pregnant female rats. Am. J. Physiol. Renal Physiol. 293: F1450–F1460.
  • Järup, L., Persson, B., and Elinder, C. G. 1995. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup. Environ. Med. 52: 818–822.
  • Järup, L. 2002. Cadmium overload and toxicity. Nephrol. Dial. Transplant 17(suppl. 2): 35–39.
  • Johri, N., Jacquillet, G., and Unwin, R. 2010. Heavy metal poisoning: The effects of cadmium on the kidney. Biometals 23: 783–792.
  • Krishnamoorthy, A., Clement, M. E., O’Leary, E., Bonventre, J. V., and Vaidya, V. S. 2010. TIM2 gene deletion results in susceptibility to cisplatin-induced kidney toxicity. Toxicol. Sci. 118: 298–306.
  • Lee, Y. K., Park, E. Y., Kim, S., Son, J. Y., Kim, T. H., Kang, W. G., Jeong, T. C., Kim, K. B., Kwack, S. J., Lee, J., Kim, S., Lee, B. M., and Kim, H. S. 2014. Evaluation of cadmium-induced nephrotoxicity using urinary metabolomic profiles in sprague-dawley male rats. J. Toxicol. Environ. Health A 77: 1384–1398.
  • Lin, H. Y., Lee, S. C., Lin, S. F., Hsiao, H. H., Liu, Y. C., Yang, W. C., Hwang, D. Y., Hung, C. C., Chen, H. C., and Guh, J. Y. 2013. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J. Med. Sci. 29: 304–311.
  • Makri, A., Goveia, M., Balbus, J., and Parkin, R. 2004. Children’s susceptibility to chemicals: A review by developmental stage. J. Toxicol. Environ. Health B Crit. Rev. 7: 417–435.
  • Malik, P., Katyal, V., Malik, V., Asatkar, A., Inwati, G., aand Mukherjee, T. K. 2013. Nanobiosensors: Concepts and variations. ISRN Nanomater. 10: 327–35. doi:10.1155/2013/327435
  • McDuffie, J. E., Ma, J. Y., Sablad, M., Sonee, M., Varacallo, L., Louden, C., Guy, A., Vegas, J., Liu, X., La, D., and Snook, S. 2013. Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration. Int. J. Toxicol. 32: 251–260.
  • McWilliam, S. J., Antoine, D. J., Sabbisetti, V., Turner, M. A., Farragher, T., Bonventre, J. V., Park, B. K., Smyth, R. L., and Pirmohamed, M. 2012. Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: A proof-of-concept study. PLoS ONE 7: e43809.
  • Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., and Devarajan, P. 2003. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14: 2534–2543.
  • Navas-Acien, A., Tellez-Plaza, M., Guallar, E., Muntner, P., Silbergeld, E., Jaar, B., and Weaver, V. 2009. Blood cadmium and lead and chronic kidney disease in US adults: A joint analysis. Am. J. Epidemiol. 170: 1156–1164.
  • Nawrot, T. S., Van Hecke, E., Thijs, L., Richart, T., Kuznetsova, T., Jin, Y., Vangronsveld, J., Roels, H. A., and Staessen, J. A. 2008. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ. Health Perspect. 116: 1620–1628.
  • Occupational Safety & Health Administration. 2012. Chemical Sampling Information/Cadmium. http://www.osha.gov/dts/chemicalsampling/data/CH_223897.html ( accessed January 18, 2015).
  • Ogueh, O., Clough, A., Hancock, M., and Johnson, M. R. 2011. A longitudinal study of the control of renal and uterine hemodynamic changes of pregnancy. Hypertens. Pregnancy 30: 243–259.
  • Orisakwe, O. E., Nwachukwu, E., Osadolor, H. B., Afonne, O. J., and Okocha, C. E. 2007. Liver and kidney function tests amongst paint factory workers in Nkpor, Nigeria. Toxicol. Ind. Health 23: 161–165.
  • Pennemans, V., De Winter, L. M., Munters, E., Nawrot, T. S., Van Kerkhove, E., Rigo, J. M., Reynders, C., Dewitte, H., Carleer, R., Penders, J., and Swennen, Q. 2011. The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ. Health 10: 77.
  • Prozialeck, W. C., Lamar, P. C., and Lynch, S. M. 2003. Cadmium alters the localization of N-cadherin, E-cadherin, and beta-catenin in the proximal tubule epithelium. Toxicol. Appl. Pharmacol. 189: 180–195.
  • Prozialeck, W. C., Vaidya, V. S., Li, J., Waalkes, M. P., Edwards, J. R., Lamar, P. C., Bernard, A. M., Dumont, X., and Bonventre, J. V. 2007. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 72: 985–993.
  • Prozialeck, W. C., Edwards, J. R., Vaidya, V. S., and Bonventre, J. V. 2009. Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. Toxicol. Appl. Pharmacol. 238: 301–305.
  • Satarug, S., Baker, J. R., Urbenjapol, S., Haswell-Elkins, M., Reilly, P. E., Williams, D. J., and Moore, M. R. 2003. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol. Lett. 137: 65–83.
  • Shoucri, R. M., and Pouliot, M. 1977. Some observations on the kinetics of the Jaffe reaction for creatinine. Clin. Chem. 23: 1527–1530.
  • Spandidos, A., Wang, X., Wang, H., and Seed, B. 2010. PrimerBank: A resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 38: D792–D799.
  • Stapleton, P. A., Minarchick, V. C., Yi, J., Engels, K., McBride, C. R., and Nurkiewicz, T. R. 2013. Maternal engineered nanomaterial exposure and fetal microvascular function: Does the Barker hypothesis apply? Am. J. Obstet. Gynecol. 209(3): 227.e1–e11.
  • Stapleton, P. A., Nichols, C. E., Yi, J., McBride, C. R., Minarchick, V. C., Shepherd, D. L., Hollander, J. M., and Nurkiewicz, T. R. 2014. Microvascular and mitochondrial dysfunction in the female F1 generation after gestational TiO2 nanoparticle exposure. Nanotoxicology 5: 1–11.
  • Supavekin, S., Zhang, W., Kucherlapati, R., Kaskel, F. J., Moore, L. C., and Devarajan, P. 2003. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 63: 1714–1724.
  • Suwazono, Y., Sand, S., Vahter, M., Skerfving, S., Lidfeldt, J., and Akesson, A. 2010. Benchmark dose for cadmium-induced osteoporosis in women. Toxicol. Lett. 197: 123–127.
  • Thomas, L. D., Hodgson, S., Nieuwenhuijsen, M., and Järup, L. 2009. Early kidney damage in a population exposed to cadmium and other heavy metals. Environ. Health Perspect. 117: 181–184.
  • Thompson, J., and Bannigan, J. 2008. Cadmium: Toxic effects on the reproductive system and the embryo. Reprod. Toxicol. 25: 304–315.
  • U.S. Environmental Protection Agency. 2011. Exposure factors handbook. http://www.epa.gov/ncea/efh/pdfs/efh-chapter06.pdf ( accessed February 25, 2015).
  • Vaidya, V. S., Waikar, S. S., Ferguson, M. A., Collings, F. B., Sunderland, K., Gioules, C., Bradwin, G., Matsouaka, R., Betensky, R. A., Curhan, G. C., and Bonventre, J. V. 2008. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin. Transl. Sci. 1: 200–208.
  • Wu, B., Sahoo, D., and Brooks, J. D. 2013. Comprehensive gene expression changes associated with mouse postnatal kidney development. J. Urol. 189: 2385–2390.
  • Yu, H. S., and Chan, S. T. 1987. Effects of cadmium on preimplantation and early postimplantation mouse embryos in vitro with special reference to their trophoblastic invasiveness. Pharmacol. Toxicol. 60: 129–134.
  • Zandi-Nejad, K., Luyckx, V. A., and Brenner, B. M. 2006. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 47: 502–508.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.